Other languages Fusion Antibodies plc

Equities

Delayed London S.E. Other stock markets 07:41:40 2024-05-21 am EDT			5-day change	1st Jan Change
3.38 ^GBX	-2.03%		-0.59%	-20.47%

Apr. 30	EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	AN
Apr. 15	Fusion Antibodies inks commercial contract for OptiPhage library	AN

EARNINGS AND TRADING: Software Circle & Beximco report higher revenue	Apr. 30
Fusion Antibodies inks commercial contract for OptiPhage library	Apr. 15
Fusion Antibodies plc Enters into Commercial Contract to Develop a Bespoke OptiPhageTM Library	Apr. 15
Sondrel wins USD23 million contract	Feb. 27
Fusion Antibodies Lands Antibodies Contract with Diagnostics Company	Feb. 27
Fusion Antibodies plc Receives First Purchase Order Under the Master Services Agreement	Feb. 27
Fusion Antibodies raises GBP1.4 million via placing	Feb. 14
Fusion Antibodies Raises GBP1 Million via Share Issue	Feb. 14
Fusion Antibodies strikes follow-on research and development project	Feb. 06
Fusion Antibodies Receives Follow-On Project from US Biotechnology Client	Feb. 06
AIM WINNERS & LOSERS: Beeks Financial Cloud is ahead of expectations	Feb. 06
Fusion Antibodies plc Receives Follow-On Project Award and R&D Update	Feb. 06
Fusion Antibodies gets tax credit from UK HMRC for OptiMAL platform	Feb. 01
Fusion Antibodies Receives R&D Tax Credit from UK Government	Feb. 01
FTSE 100 slips as miners hold down index	Dec. 04
Fusion Antibodies shares fall with revenue despite "positive" outlook	Dec. 04
AIM WINNERS & LOSERS: Cornerstone FS to beat 2023 expectations	Dec. 04
Fusion Antibodies plc Reports Earnings Results for the Half Year Ended September 30, 2023	Dec. 04
Fusion Antibodies shares up on deal with US National Cancer Institute	Nov. 28
AIM WINNERS & LOSERS: Totally swings to half-year loss on NHS blow	Nov. 28

No results for this search